Cargando…

Comparative effectiveness of rosuvastatin versus simvastatin in primary prevention among new users: a cohort study in the French national health insurance database

PURPOSE: Using the French claims database (Système National d'Information Inter-Régimes de l'Assurance Maladie) linked to the hospital discharge database (Programme de Médicalisation des Systèmes d'Information), this observational study compared the effectiveness of rosuvastatin and s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Neumann, Anke, Maura, Géric, Weill, Alain, Ricordeau, Philippe, Alla, François, Allemand, Hubert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BlackWell Publishing Ltd 2014
Materias:	Original Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4265280/ https://www.ncbi.nlm.nih.gov/pubmed/24292987 http://dx.doi.org/10.1002/pds.3544

Ejemplares similares

Does Insulin Glargine Increase the Risk of Cancer Compared With Other Basal Insulins?: A French nationwide cohort study based on national administrative databases
por: Fagot, Jean-Paul, et al.
Publicado: (2013)

Use of Fibrates Monotherapy in People with Diabetes and High Cardiovascular Risk in Primary Care: A French Nationwide Cohort Study Based on National Administrative Databases
por: Roussel, Ronan, et al.
Publicado: (2015)

Prevalence and mortality of patients with multiple sclerosis in France in 2012: a study based on French health insurance data
por: Foulon, Stéphanie, et al.
Publicado: (2017)

Oral anticoagulation therapy use in patients with atrial fibrillation after the introduction of non-vitamin K antagonist oral anticoagulants: findings from the French healthcare databases, 2011–2016
por: Maura, Géric, et al.
Publicado: (2019)

Comparison of the Short-Term Risk of Bleeding and Arterial Thromboembolic Events in Nonvalvular Atrial Fibrillation Patients Newly Treated With Dabigatran or Rivaroxaban Versus Vitamin K Antagonists: A French Nationwide Propensity-Matched Cohort Study
por: Maura, Géric, et al.
Publicado: (2015)

Adherence with direct oral anticoagulants in nonvalvular atrial fibrillation new users and associated factors: a French nationwide cohort study
por: Maura, Géric, et al.
Publicado: (2017)

Non-bleeding Adverse Events with the Use of Direct Oral Anticoagulants: A Sequence Symmetry Analysis
por: Maura, Géric, et al.
Publicado: (2018)

Oral anticoagulants and risk of acute liver injury in patients with nonvalvular atrial fibrillation: a propensity-weighted nationwide cohort study
por: Maura, Géric, et al.
Publicado: (2020)

Pioglitazone and risk of bladder cancer among diabetic patients in France: a population-based cohort study
por: Neumann, A., et al.
Publicado: (2012)

Low dose oestrogen combined oral contraception and risk of pulmonary embolism, stroke, and myocardial infarction in five million French women: cohort study
por: Weill, Alain, et al.
Publicado: (2016)

Healthcare expenditure of multiple sclerosis patients in 2013: A nationwide study based on French health administrative databases
por: Lefeuvre, Delphine, et al.
Publicado: (2017)

Antibacterial activity of statins: a comparative study of Atorvastatin, Simvastatin, and Rosuvastatin
por: Masadeh, Majed, et al.
Publicado: (2012)

Protective effect of simvastatin and rosuvastatin on trinitrobenzene sulfonic acid-induced colitis in rats
por: Maheshwari, Rajesh A., et al.
Publicado: (2015)

Dispensing of Potentially Harmful Prescription Drugs in 1.8 Million Pregnant Women in France: A Nationwide Study Based on Two Risk Classification Systems
por: Blotière, Pierre-Olivier, et al.
Publicado: (2021)

Relationship between genetic polymorphism of drug transporters and the efficacy of Rosuvastatin, atorvastatin and simvastatin in patients with hyperlipidemia
por: Sivkov, Andrey, et al.
Publicado: (2021)

Adherence with brand versus generic bisphosphonates among osteoporosis patients: a new-user cohort study in the French National Healthcare Insurance database
por: Viprey, Marie, et al.
Publicado: (2020)

Insulin glargine and risk of cancer: a cohort study in the French National Healthcare Insurance Database
por: Blin, P., et al.
Publicado: (2012)

A comparative evaluation of safety and efficacy of rosuvastatin, simvastatin, and atorvastatin in patients of type 2 diabetes mellitus with dyslipidemia
por: Adsule, Samir Maruti, et al.
Publicado: (2009)

Cost-effectiveness of rosuvastatin in comparison with generic atorvastatin and simvastatin in a Swedish population at high risk of cardiovascular events
por: Gandhi, Sanjay K, et al.
Publicado: (2012)

Effects of ezetimibe/simvastatin 10/10 mg versus Rosuvastatin 10 mg on carotid atherosclerotic plaque inflammation
por: Oh, Minyoung, et al.
Publicado: (2019)

Costs and mortality associated with HIV: a machine learning analysis of the French national health insurance database
por: Prodel, Martin, et al.
Publicado: (2021)

Effects of Fostamatinib on the Pharmacokinetics of Oral Contraceptive, Warfarin, and the Statins Rosuvastatin and Simvastatin: Results From Phase I Clinical Studies
por: Martin, P., et al.
Publicado: (2016)

Ezetimibe/Simvastatin 10/20 mg versus Rosuvastatin 10 mg in high-risk hypercholesterolemic patients stratified by prior statin treatment potency
por: Viigimaa, Margus, et al.
Publicado: (2010)

Cardiovascular effect of discontinuing statins for primary prevention at the age of 75 years: a nationwide population-based cohort study in France
por: Giral, Philippe, et al.
Publicado: (2019)

Vaccination during the First Diagnosis of Multiple Myeloma: A Cohort Study of the French National Health Insurance Database
por: Tournaire, Guilhem, et al.
Publicado: (2020)

Care pathways in invasive meningococcal disease: a retrospective analysis of the French national public health insurance database
por: Weil-Olivier, Catherine, et al.
Publicado: (2022)

Risk factors for invasive meningococcal disease: a retrospective analysis of the French national public health insurance database
por: Taha, Muhamed-Kheir, et al.
Publicado: (2021)

Changes in LDL-C levels and goal attainment associated with addition of ezetimibe to simvastatin, atorvastatin, or rosuvastatin compared with titrating statin monotherapy
por: Foody, JoAnne M, et al.
Publicado: (2013)

Effects of Ezetimibe/Simvastatin and Rosuvastatin on Oxidative Stress in Diabetic Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
por: Villegas-Rivera, Geannyne, et al.
Publicado: (2015)

Sub-gingival delivery of simvastatin and rosuvastatin for treatment of chronic periodontitis with diabetes mellitus: A randomized controlled clinical-radiographic pilot study
por: Sharma, Pallavi, et al.
Publicado: (2023)

Antidepressants and Hepatotoxicity: A Cohort Study among 5 Million Individuals Registered in the French National Health Insurance Database
por: Billioti de Gage, Sophie, et al.
Publicado: (2018)

Is There a Cardiotoxicity Associated With Metallic Head Hip Prostheses? A Cohort Study in the French National Health Insurance Databases
por: Lassalle, Marion, et al.
Publicado: (2018)

Osteoporosis prevention among chronic glucocorticoid users: results from a public health insurance database
por: Trijau, Sophie, et al.
Publicado: (2016)

Cardiovascular Events, Sleep Apnoea, and Pulmonary Hypertension in Primary Sjögren’s Syndrome: Data from the French Health Insurance Database
por: Goulabchand, Radjiv, et al.
Publicado: (2021)

The French glioblastoma biobank (FGB): a national clinicobiological database
por: Clavreul, Anne, et al.
Publicado: (2019)

Effect of Roxadustat on the Pharmacokinetics of Simvastatin, Rosuvastatin, and Atorvastatin in Healthy Subjects: Results From 3 Phase 1, Open‐Label, 1‐Sequence, Crossover Studies
por: Groenendaal‐van de Meent, Dorien, et al.
Publicado: (2022)

(De)Prescribing of proton pump inhibitors: what has changed in recent years? an observational regional study from the French health insurance database
por: Gendre, Pauline, et al.
Publicado: (2022)

Current Perspectives on rosuvastatin
por: Hu, Miao, et al.
Publicado: (2013)

Correction to: The French glioblastoma biobank (FGB): a national clinicobiological database
por: Clavreul, Anne, et al.
Publicado: (2020)

Alzheimer's disease: Estimating its prevalence rate in a French geographical unit using the National Alzheimer Data Bank and national health insurance information systems
por: Bailly, Laurent, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_81rptbfembg6hk1maattabh8ub